CJ Cheiljedang is targetting sales of 200 billion won in plant-based foods by 2025, setting it as the company’s new growth engine. The South Korean food conglomerate's main target is overseas markets where it aims to generate 70 percent of its sales.
Jung Hyun-hak, the head of CJ’s plant-based food business, noted that the three trends of health and wellness, sustainability, and animal welfare merge that is making plant-based food a global megatrend.
He added that they expect the global plant-based food market to grow up to 35 trillion won in the next 10 years.
According to CJ, the 2.64 trillion won the global market for plant-based food is expanding by double digits annually. This year's domestic market is estimated to be worth 14.1 billion won, an increase of 104.3 percent from 2018.
CJ debuted vegan dumplings and kimchi under its independent plant-based cuisine brand PlanTable last December to tap into the expanding vegan market both inside and outside of South Korea.
Textured Vegetable Protein (TVP), a plant-based protein substitute created by the company utilizing soy and peas, was introduced this month by CJ along with meatless "tteokgalbi," grilled short rib patties, and other protein products.
Since its inception six months ago, PlanTable products have been offered in 20 different nations, including the US, Japan, and Australia.
The food manufacturer has added a different production line to its No. 2 factory in Incheon, roughly 30 kilometers west of Seoul, as well as increased its production capacity. According to CJ, the new line can produce 1,000 tons annually.
For its expanding international companies, it said it is taking into consideration a plan to construct a second vegan production facility.
Due to the significant vegan population and the developed markets for plant-based substitutes, the US and European markets are its primary targets, according to Jung.


United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Gold Prices Dip as Markets Absorb Dovish Fed Outlook; Silver Eases After Record High
Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only
Oil Prices Rebound in Asia as Venezuela Sanctions Risks Offset Ukraine Peace Hopes
Nvidia Develops New Location-Verification Technology for AI Chips
LA fires: Long-term exposure to wildfire smoke is poorly understood − and a growing risk
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO
Lake beds are rich environmental records — studying them reveals much about a place’s history
BOJ Expected to Deliver December Rate Hike as Economists See Borrowing Costs Rising Through 2025
S&P 500 Slides as AI Chip Stocks Tumble, Cooling Tech Rally
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 



